ScholarLens Back to search
2015•Leukemia ResearchRequires access

14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

Rami S. Komrokji, G. García-Manero, Lionel Adès, A. Laadem, Bond Vo, Thomas Prébet, Aspasia Stamatoullas, Thomas E. Boyd, Jean Delaunay, David P. Steensma, Mikkael Aaron Sekeres, Odile Beyne‐Rauzy, Jinfeng Zou, K.M. Attie, ML Sherman, Pierre Fenaux, Alan F. List

Open publisher page 11 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Chronic myelomonocytic leukemia, Myelodysplastic syndromes, Medicine, Anemia, Leukemia, Internal medicine, Bone marrow

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION — Research Paper | ScholarLens